Melitracen (brand names Melixeran) is a tricyclic antidepressant (TCA), for the treatment of depression and anxiety. In addition to single drug preparations, it is also available as Deanxit, marketed by Lundbeck, a combination product containing both melitracen and flupentixo

Market Analysis and Insights: Global Melitracen Market
In 2020, the global Melitracen market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% between 2021 and 2027
Global Melitracen Scope and Market Size
The global Melitracen market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Melitracen market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), byType, and by Application for the period 2016-2027.

Segment by Type
Single Drug Preparations
Mixture Drug Preparations

Segment by Application
Hospital
Drug Store

By Company
Lundbeck
General Pharma
Rangs Group
Unimed and Unihealth
Drug International
Somatec Pharmaceuticals
Mankind Pharma
Molekule
Helios Pharmaceutical
East West Pharma
Union Medical
Aristopharma
Bio-Pharma
ACI Pharmaceuticals

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Colombia
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE